Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (281-290 of 327) with videos related to

Pageof 33
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosisM Chawla-Sarkar, D J Lindner, Y-F Liu, et al.
Cancer Treatment Reports|July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusionR H Earhart, J M Koeller, T E Davis, et al.
Cancer Research|January 1, 1988
Biotechnology products in cancer therapy: a colloquiumE C Borden, E C Bradley, C H Evans, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2Douglas W Leaman, Mamta Chawla-Sarkar, Barbara Jacobs, et al.
American Journal of Dentistry|January 5, 2002
Clinical effectiveness of essential oil-containing dentifrices in controlling oral malodorA M Olshan, B E Kohut, J W Vincent, et al.
Journal of Biological Response Modifiers|August 1, 1990
Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycleJ H Schiller, M A Horisberger, G Bittner, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanomaD A Amato, H Bruckner, D Guerry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.
Cancer|January 1, 1986
Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancerA Y Chang, J P Kuebler, D C Tormey, et al.
Pageof 33

Showing results (281-290 of 327) with videos related to

Sort By:
Pageof 33
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosisM Chawla-Sarkar, D J Lindner, Y-F Liu, et al.
Cancer Treatment Reports|July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusionR H Earhart, J M Koeller, T E Davis, et al.
Cancer Research|January 1, 1988
Biotechnology products in cancer therapy: a colloquiumE C Borden, E C Bradley, C H Evans, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2Douglas W Leaman, Mamta Chawla-Sarkar, Barbara Jacobs, et al.
American Journal of Dentistry|January 5, 2002
Clinical effectiveness of essential oil-containing dentifrices in controlling oral malodorA M Olshan, B E Kohut, J W Vincent, et al.
Journal of Biological Response Modifiers|August 1, 1990
Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycleJ H Schiller, M A Horisberger, G Bittner, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanomaD A Amato, H Bruckner, D Guerry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.
Cancer|January 1, 1986
Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancerA Y Chang, J P Kuebler, D C Tormey, et al.
Pageof 33